Tech Company Financing Transactions

BioScale Funding Round

On 3/7/2012, BioScale raised $5.3 million in funding from private investors.

Transaction Overview

Company Name
Announced On
3/7/2012
Transaction Type
Debt
Amount
$5,261,050
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Fortune Dr.
Lexington, MA 01821
USA
Email Address
Overview
Bioscale develops a protein measurement technology that accelerates the discovery and development of biological and pharmaceutical products.
Profile
BioScale LinkedIn Company Profile
Social Media
BioScale Company Twitter Account
Company News
BioScale News
Facebook
BioScale on Facebook
YouTube
BioScale on YouTube

Management Team

Title
Name
Email & Social
Chief Scientific Officer
Martin Latterich
  Martin Latterich LinkedIn Profile  Martin Latterich Twitter Account  Martin Latterich News  Martin Latterich on Facebook
Chief Technical Officer
Brett Masters
  Brett Masters LinkedIn Profile  Brett Masters Twitter Account  Brett Masters News  Brett Masters on Facebook
Co-Founder
Mark Lundstrom
  Mark Lundstrom LinkedIn Profile  Mark Lundstrom Twitter Account  Mark Lundstrom News  Mark Lundstrom on Facebook
VP - Product Management
Michael Miller
  Michael Miller LinkedIn Profile  Michael Miller Twitter Account  Michael Miller News  Michael Miller on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/7/2012: Miasole venture capital transaction
Next: 3/7/2012: Quotient Biodiagnostics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary